European Medicines Agency gives new temporary treatment recommendations for Fabrazyme

View source ↗

Summary

EMA provides new temporary treatment recommendations for Fabrazyme, outlining updated dosing or usage guidance while further evaluations continue.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease

Drugs mentioned

• FABRAZYME (Agalsidase beta)